Stephen V Liu, MD (@stephenvliu) 's Twitter Profile
Stephen V Liu, MD

@stephenvliu

Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Co-Host @IASLC Podcast; Chair #TexasLung25 #DCLung25; #HereWeGo

ID: 377425889

linkhttps://www.medstarhealth.org/doctors/stephen-liu-md calendar_today21-09-2011 15:17:53

19,19K Tweet

26,26K Followers

3,3K Following

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo
Stephen V Liu, MD
@stephenvliu

2 months ago

Retrospective study of neoadjuvant immunotherapy for 112 pts with stage III borderline resectable NSCLC JAMA Oncology. Included stage III with T4 and/or N2/3 NSCLC and 75% underwent surgery with 29% pCR, 42.2% MPR, mEFS 52.6m. Impressive to note that all N3 achieved ypN0.

Retrospective study of neoadjuvant immunotherapy for 112 pts with stage III borderline resectable NSCLC <a href="/JAMAOnc/">JAMA Oncology</a>. Included stage III with T4 and/or N2/3 NSCLC and 75% underwent surgery with 29% pCR, 42.2% MPR, mEFS 52.6m. Impressive to note that all N3 achieved ypN0.